In-/Out-Licensing
Streptokinase
Thrombolytik agent
Use
- Acued myocardial infarction
- Severe thrombosis
Pharmaceutical form and presentations
- 1.5 mio IU
- 750.000 IU
- 250.000 IU
Produced in
- European Union
Available countries
- On request
Regulatory status, indications and product information may vary from country to country.
Product descriptions provide basic information and are not usage instructions.
Please observe the officially approved information.